|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liao D, Luo Y, Markowitz D, Xiang R and
Reisfeld RA: Cancer associated fibroblasts promote tumor growth and
metastasis by modulating the tumor immune microenvironment in a 4T1
murine breast cancer model. PLoS One. 4:e79652009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu P, Baek SH, Bourk EM, Ohgi KA,
Garcia-Bassets I, Sanjo H, Akira S, Kotol PF, Glass CK, Rosenfeld
MG, et al: Macrophage/cancer cell interactions mediate hormone
resistance by a nuclear receptor derepression pathway. Cell.
124:615–629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeng Y, Opeskin K, Goad J and Williams ED:
Tumor-induced activation of lymphatic endothelial cells via
vascular endothelial growth factor receptor-2 is critical for
prostate cancer lymphatic metastasis. Cancer Res. 66:9566–9575.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gabbiani G, Ryan GB and Majne G: Presence
of modified fibroblasts in granulation tissue and their possible
role in wound contraction. Experientia. 27:549–550. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier
C and Brown RA: Myofibroblasts and mechano-regulation of connective
tissue remodelling. Nat Rev Mol Cell Biol. 3:349–363. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Franco OE, Shaw AK, Strand DW and Hayward
SW: Cancer associated fibroblasts in cancer pathogenesis. Semin
Cell Dev Biol. 21:33–39. 2010. View Article : Google Scholar :
|
|
8
|
Zhao H and Peehl DM: Tumor-promoting
phenotype of CD90hi prostate cancer-associated fibroblasts.
Prostate. 69:991–1000. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo J, Ok Lee S, Liang L, Huang CK, Li L,
Wen S and Chang C: Infiltrating bone marrow mesenchymal stem cells
increase prostate cancer stem cell population and metastatic
ability via secreting cytokines to suppress androgen receptor
signaling. Oncogene. 33:2768–2778. 2014. View Article : Google Scholar
|
|
10
|
Huang CK, Tsai MY, Luo J, Kang HY, Lee SO
and Chang C: Suppression of androgen receptor enhances the
self-renewal of mesenchymal stem cells through elevated expression
of EGFR. Biochim Biophys Acta. 1833.1222–1234. 2013.
|
|
11
|
Slavin S, Yeh CR, Da J, Yu S, Miyamoto H,
Messing EM, Guancial E and Yeh S: Estrogen receptor α in
cancer-associated fibroblasts suppresses prostate cancer invasion
via modulation of thrombospondin 2 and matrix metalloproteinase 3.
Carcinogenesis. 35:1301–1309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tuxhorn JA, Ayala GE, Smith MJ, Smith VC,
Dang TD and Rowley DR: Reactive stroma in human prostate cancer:
induction of myofibroblast phenotype and extracellular matrix
remodeling. Clin Cancer Res. 8:2912–2923. 2002.PubMed/NCBI
|
|
13
|
Reinertsen T, Halgunset J, Viset T,
Flatberg A, Haugsmoen LL and Skogseth H: Gene expressional changes
in prostate fibroblasts from cancerous tissue. APMIS. 120:558–571.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cirri P and Chiarugi P: Cancer associated
fibroblasts: The dark side of the coin. Am J Cancer Res. 1:482–497.
2011.PubMed/NCBI
|
|
15
|
Haubeiss S, Schmid JO, Mürdter TE,
Sonnenberg M, Friedel G, van der Kuip H and Aulitzky WE: Dasatinib
reverses cancer-associated fibroblasts (CAFs) from primary lung
carcinomas to a phenotype comparable to that of normal fibroblasts.
Mol Cancer. 9:1682010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishii K, Mizokami A, Tsunoda T, Iguchi K,
Kato M, Hori Y, Arima K, Namiki M and Sugimura Y: Heterogenous
induction of carcinoma-associated fibroblast-like differentiation
in normal human prostatic fibroblasts by co-culturing with prostate
cancer cells. J Cell Biochem. 112:3604–3611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cirri P and Chiarugi P:
Cancer-associated-fibroblasts and tumour cells: A diabolic liaison
driving cancer progression. Cancer Metastasis Rev. 31:195–208.
2012. View Article : Google Scholar
|
|
18
|
Miyamoto H, Messing EM and Chang C:
Androgen deprivation therapy for prostate cancer: Current status
and future prospects. Prostate. 61:332–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke
WA, Messing EM, Yao J, Yeh S and Chang C: Androgen receptor is a
tumor suppressor and proliferator in prostate cancer. Proc Natl
Acad Sci USA. 105:12182–12187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SO, Tian J, Huang CK, Ma Z, Lai KP,
Hsiao H, Jiang M, Yeh S and Chang C: Suppressor role of androgen
receptor in proliferation of prostate basal epithelial and
progenitor cells. J Endocrinol. 213:173–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Lee SO, Xia S, Jiang Q, Luo J, Li
L, Yeh S and Chang C: Endothelial cells enhance prostate cancer
metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals. Mol
Cancer Ther. 12:1026–1037. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Izumi K, Fang LY, Mizokami A, Namiki M, Li
L, Lin WJ and Chang C: Targeting the androgen receptor with siRNA
promotes prostate cancer metastasis through enhanced macrophage
recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol Med.
5:1383–1401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gonda TA, Varro A, Wang TC and Tycko B:
Molecular biology of cancer-associated fibroblasts: Can these cells
be targeted in anti-cancer therapy? Semin Cell Dev Biol. 21:2–10.
2010. View Article : Google Scholar
|
|
24
|
Navab R, Strumpf D, Bandarchi B, Zhu CQ,
Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L,
Barczyk M, et al: Prognostic gene-expression signature of
carcinoma-associated fibroblasts in non-small cell lung cancer.
Proc Natl Acad Sci USA. 108:7160–7165. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeisberg EM, Potenta S, Xie L, Zeisberg M
and Kalluri R: Discovery of endothelial to mesenchymal transition
as a source for carcinoma-associated fibroblasts. Cancer Res.
67:10123–10128. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mishra PJ, Mishra PJ, Humeniuk R, Medina
DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW and Banerjee D:
Carcinoma-associated fibroblast-like differentiation of human
mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Direkze NC, Hodivala-Dilke K, Jeffery R,
Hunt T, Poulsom R, Oukrif D, Alison MR and Wright NA: Bone marrow
contribution to tumor-associated myofibroblasts and fibroblasts.
Cancer Res. 64:8492–8495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Comite P, Cobianchi L, Avanzini MA, Zonta
S, Mantelli M, Achille V, De Martino M, Cansolino L, Ferrari C,
Alessiani M, et al: Isolation and ex vivo expansion of bone
marrow-derived porcine mesenchymal stromal cells: Potential for
application in an experimental model of solid organ transplantation
in large animals. Transplant Proc. 42:1341–1343. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Chen Z and Bie P: Bone
marrow-derived mesenchymal stem cells as immunosuppressants in
liver transplantation: A review of current data. Transfus Med Rev.
26:129–141. 2012. View Article : Google Scholar
|
|
30
|
Placencio VR, Li X, Sherrill TP, Fritz G
and Bhowmick NA: Bone marrow derived mesenchymal stem cells
incorporate into the prostate during regrowth. PLoS One.
5:e129202010. View Article : Google Scholar : PubMed/NCBI
|
